We have observed
4 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after March 17, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
BIOTECHNOLOGICAL PRODUCTION OF CHONDROITIN
FLUORINATED ARYLALKYLAMINOCARBOXAMIDE DERIVATIVES
A COMPLEX OF AMORPHOUS TOMOXIPROLE AND CYCLODEXTRIN WITH FAST DISSOLUTION RATE AND PROCESS FOR THE PREPARATION THEREOF
NEW PROTEASES ABLE TO HYDROLYZE GLUTEN PEPTIDES AND PROTEINS AT ACIDIC PH, FROM THE ACTINOMYCETE ACTINOALLOMURUS